Tech Company Financing Transactions
Isomorphic Labs Funding Round
Isomorphic Labs, operating out of London, secured investment capital from Novartis.
Transaction Overview
Company Name
Announced On
1/7/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 New Bridge Street
London, EC4V 6JA
UK
London, EC4V 6JA
UK
Phone
Undisclosed
Website
Email Address
Overview
Isomorphic Labs was born in 2021 to apply AI and computational methods to drug discovery, and transform the way medicine helps and heals people. We're building on the AlphaFold breakthrough in active partnership with Google DeepMind, united together as members of the Alphabet family.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Demis Hassabis
Chief Operating Officer
Pamela Carroll
Chief Scientific Officer
Miles Congreve
Chief Technical Officer
Max Jaderberg
Chief Technical Officer
Sergei Yakneen
VP - Bus. Development
John Strafford
VP - General Counsel
Sarah Korman
VP - Human Resources
Beverley Mallon
Browse more venture capital transactions:
Prev: 1/6/2024: Clarametyx Biosciences venture capital transaction
Next: 1/8/2024: Rincell venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs